| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Author’s Reply to Şener and Begijanashvili: “Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy”
|
Sheng, Iris Y.
|
|
|
17 |
4 |
p. 495-496
|
artikel
|
| 2 |
Comment on: “Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy”
|
Şener, Yusuf Ziya
|
|
|
17 |
4 |
p. 493-494
|
artikel
|
| 3 |
Efficacy and Safety of Immunotherapy-Based Combinations as First-Line Therapy for Metastatic Renal Cell Carcinoma in Patients Who Do Not Meet Trial Eligibility Criteria
|
Nemoto, Yuki
|
|
|
17 |
4 |
p. 475-482
|
artikel
|
| 4 |
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP
|
Dubois, Fatéméh
|
|
|
17 |
4 |
p. 407-431
|
artikel
|
| 5 |
Pattern of Clinical Progression Until Metastatic Castration-Resistant Prostate Cancer: An Epidemiological Study from the European Prostate Cancer Registry
|
Verry, Camille
|
|
|
17 |
4 |
p. 441-451
|
artikel
|
| 6 |
Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer
|
Tan, Elaine S.
|
|
|
17 |
4 |
p. 483-492
|
artikel
|
| 7 |
Real-World Data on Pembrolizumab for Pretreated Non-Small-Cell Lung Cancer: Clinical Outcome and Relevance of the Lung Immune Prognostic Index
|
Ortega-Franco, Ana
|
|
|
17 |
4 |
p. 453-465
|
artikel
|
| 8 |
Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study
|
Maruzzo, Marco
|
|
|
17 |
4 |
p. 467-474
|
artikel
|
| 9 |
Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
|
Girgis, Suzette
|
|
|
17 |
4 |
p. 433-439
|
artikel
|
| 10 |
What’s Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple Myeloma
|
Costa, Bruno Almeida
|
|
|
17 |
4 |
p. 383-405
|
artikel
|
Tijdschrift beschrijving